Perella Weinberg

SANTA MONICA, Calif. and VANCOUVER, March 19 /PRNewswire-FirstCall/ -- Lionsgate (NYSE: LGF), today announced that it has received a revised unsolicited tender offer from the Icahn Group to acquire up to all of Lionsgate's common shares for an unchanged price of USD $6.00 per share in cash.   Consistent with its fiduciary duties and in consultation with its Special Committee and financial and legal advisors, Lionsgate's Board of Directors will review Mr. Icahn's revised offer and will make its recommendation to shareholders promptly.  The Company noted that the Icahn Group's revised tender offer does not increase the price of the original offer. The Board of Directors' recommendation will be included in an amended Solicitation/Recommendation Statement filing on a Schedule 14D-9.  Lionsgate added that there is no need for shareholders to take any action at this time.   Morgan Stanley is serving as financial advisor to Lionsgate and Heenan Blaikie LLP is serving as ...

SANTA MONICA, Calif. and VANCOUVER, British Columbia, March 12 /PRNewswire-FirstCall/ -- Lionsgate (NYSE: LGF) today announced that its Board of Directors, in consultation with its financial and legal advisors, has determined, by unanimous vote of the directors present, that the unsolicited partial tender offer from Carl Icahn and certain of his affiliated entities (the "Icahn Group") to purchase up to 13,164,420 common shares of Lionsgate for $6.00 per share is financially inadequate and coercive and is not in the best interests of Lionsgate and its shareholders and other stakeholders.  The Board strongly recommends that Lionsgate shareholders not tender their shares into the Icahn Group offer.   The basis for the Board's recommendation with respect to the Icahn Group's unsolicited partial tender offer, which followed a thorough review of the offer by a Special Committee of the Board, is set forth in Lionsgate's Schedule 14D-9 filed today with the Securities and Exchange ...

Event Draws Strong Support From Corporate Restructuring & Finance Community NEW YORK, March 10 /PRNewswire-USNewswire/ -- The Michael Lynch Memorial Foundation, a scholarship program that has provided more than $1.2 million in grants to enable children of firefighters and other victims of the September 11 attacks and other fires and disasters to afford higher education, today announced that broadcast journalists Dick Brennan of Fox 5 News and Marie Hickey of EXTRA have agreed to serve as the Masters of Ceremonies at the Foundation's eighth annual dinner.  The event will be held on Monday, March 22, 2010 at The Lighthouse at Chelsea Piers in Manhattan. The Foundation also announced today that the annual dinner, chaired by Jonathan S. Henes, a partner in the Restructuring Group at Kirkland & Ellis LLP, has received strong financial support from the corporate restructuring and finance community, including law firms, financial advisory firms and turnaround consultants. The Michael Lynch Memorial ...

Moves Forward on Strongest Financial Footing in Company's History with Approximately 60% Less Debt, Reduced Annual Interest Expense, Stronger Balance Sheet and Substantially Increased Liquidity BOSTON--(BUSINESS WIRE)-- Houghton Mifflin Harcourt Publishing Company (HMH) today announced the successful completion of its balance sheet recapitalization in which HMH is receiving a $650 million investment of new equity capital from a deep institutionalized investor base. These activities strengthen HMH's ...

DARMSTADT, Germany and BILLERICA, Mass., Feb. 28 /PRNewswire-FirstCall/ -- Merck KGaA, a global pharmaceutical and chemical company, and Millipore Corporation (NYSE: MIL), a leading Life Science company based in Billerica, Massachusetts, USA, today announced that they have entered into a definitive agreement under which Merck KGaA will acquire all outstanding shares of common stock of Millipore, for US$ 107 per share in cash, or a total transaction value, including net debt, of approximately EUR 5.3 billion (US$ 7.2 billion). The transaction was approved by the boards of directors of both companies. Millipore and Merck will create a EUR 2.1 billion (US$ 2.9 billion) world-class partner for the Life Science sector, achieving significant scale in high-margin specialty products with an attractive growth profile. "This transaction is very attractive to shareholders, customers and employees of both companies," said Dr. Karl-Ludwig Kley, Chairman of the Executive Board of Merck. "This is a combination with ...